Search
for
Sort by
Research 61–90 of 1000+
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Mucosal TLR5 activation controls healthspan and longevity
- Development of growth factor-incorporating liposomes for integration into scaffolds as a method to improve tissue regeneration
- Self-Amplifying RNA Approach for Protein Replacement Therapy
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Severe Lichen Planus Pigmentosus Inversus in an Elderly Female Following Intra-Articular Injections of Homeopathic Substances
- Medical Dermatology
- Lipid Droplets from Plants and Microalgae: Characteristics, Extractions, and Applications
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- The most recent advances in understanding and managing hidradenitis suppurativa
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Filaggrin mutations as an archetype for understanding the pathophysiology of atopic dermatitis
- The PDGF/PDGFR pathway as a drug target
- Dermatological adverse events with taxane chemotherapy
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Interventions for nail psoriasis
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Expression of an Olfactomedin-Related Gene in Rat Hair Follicular Papilla Cells
- Hyperadrenocorticism in Ferrets
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells